SCHEMBL21030737

SCHEMBL21030737

COCCOc1ncc(Cl)cc1C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.43
MAPK1 P28482 8/20 0.36
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
TSHR P16473 3/20 0.34
LMNA P02545 1/20 0.34
CYP2C9 P11712 1/20 0.34
APEX1 P27695 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KCNJ5 P48544 2/20 0.34
KCNJ3 P48549 2/20 0.34
TRPV1 Q8NER1 1/20 0.33
TACR2 P21452 1/20 0.33
CNR1 P21554 1/20 0.33
SGMS2 Q8NHU3 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
P2RX3 P56373 1/20 0.32
P2RX2 Q9UBL9 1/20 0.32
POLB P06746 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20086562 0.84 GABRA1 (0.39) MAPK1GABRA1GABRB1TSHRLMNA
SCHEMBL17040561 0.83 GABRA1 (0.39) MAPK1GABRA1GABRB1TSHRLMNA
SCHEMBL21031218 0.81 CHRNA4 (0.51) SMN1; SMN2
SCHEMBL11890406 0.81 TSHR (0.43) MAPK1GABRA1GABRB1TSHRLMNA
SCHEMBL21030615 0.78 PLAU (0.47) PLAUMAPK1TSHRLMNACYP2C9
SCHEMBL18839551 0.77 PLAU (0.49) PLAUMAPK1TSHRLMNACYP2C9
SCHEMBL17812431 0.74 KCNJ5 (0.36) PLAUMAPK1TSHRKCNJ5KCNJ3
SCHEMBL18862739 0.73 PLAU (0.43) PLAUMAPK1TSHRLMNACYP2C9
SCHEMBL19823845 0.73 PLAU (0.43) PLAUMAPK1TSHRLMNACYP2C9
SCHEMBL23032776 0.72 L3MBTL1 (0.33) TSHRLMNACYP2C9APEX1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210052556-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2021-02-25 US disclosed
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LIMITED (IN) 2019-09-12 US disclosed
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210052556-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO PLAU 4721/4885MAPK1 708/4885GABRA1 2496/4885
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO PLAU 4721/4885MAPK1 708/4885GABRA1 2496/4885
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO PLAU 4721/4885MAPK1 708/4885GABRA1 2496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.